520A — J-Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for J-Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | JAS | JAS | JAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1,651 | -1,498 | -2,465 |
| Depreciation | |||
| Non-Cash Items | 191 | -89.4 | -969 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 47.1 | -108 | 1,185 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -1,411 | -1,695 | -2,249 |
| Capital Expenditures | -13.4 | -0.191 | -4.02 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -16.4 | — | 0.357 |
| Acquisition of Business | |||
| Sale of Business | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -29.7 | -0.191 | -3.67 |
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 925 | 2,924 | 4,334 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -514 | 1,229 | 2,151 |